SynMax announced that all maritime intelligence from Satellogic's Merlin satellite constellation will be exclusively available through its Theia platform beginning in 2027. Theia combines high-resolution daily satellite imagery with AIS data to detect vessels, including those that disable or spoof their signals, enhancing maritime domain awareness. This integration allows customers to monitor illicit activities like dark-fleet operations, sanctioned trade violations, and illegal fishing with greater detail and speed. The rollout starts as Satellogic launches its first Merlin satellite in late 2026, aiming to provide proactive, real-time maritime intelligence for defense, government, and commercial users worldwide.
Oculis Holding AG has completed patient randomization in its PREDICT-1 clinical trial testing Licaminlimab, a precision medicine targeting TNFR1-mediated dry eye disease (DED). Two-thirds of the 176 enrolled patients carry a genetic variant linked to...
Ekalia, a joint venture between IBA and Framatome, has signed a collaboration agreement with Telix Pharmaceuticals to accelerate the production of astatine-211 in the United States. Astatine-211 is a promising alpha-emitting radioisotope used in targ...
Red Cat Holdings announced a voluntary public purchase offer to acquire all outstanding shares of Steyr Motors AG at €39 per share in cash, representing a significant premium over recent prices. The acquisition aims to strengthen Red Cat's Blue Ops u...
At ESMO 2026, Roche presented key Phase III trial results showcasing significant advances in cancer treatment. Divarasib demonstrated superior efficacy over first-generation KRAS G12C inhibitors in advanced lung cancer, potentially setting a new stan...
Oculis Holding AG has completed patient randomization in its PREDICT-1 trial testing Licaminlimab, a precision medicine targeting TNFR1-mediated dry eye disease (DED). The trial enrolled 176 patients, two-thirds carrying a genetic variant linked to b...
